Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ENDRA Life Sciences Inc. NDRA
$1.40
+$0.02 (1.09%)
На 18:01, 12 мая 2023
+257.14%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
9950541.00000000
-
week52high
7.60
-
week52low
1.02
-
Revenue
0
-
P/E TTM
0
-
Beta
0.81107200
-
EPS
-4.84000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 07 апр 2022 г. |
| H.C. Wainwright | Buy | 15 июл 2019 г. | |
| Lake Street | Buy | 20 мая 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Michelon Francois Roger | A | 69531 | 69531 | 30 янв 2023 г. |
| Thornton Michael Milos | A | 68066 | 68066 | 30 янв 2023 г. |
| Pestrikova Irina | A | 8000 | 8000 | 30 янв 2023 г. |
| DIGIANDOMENICO ANTHONY | A | 9621 | 9621 | 30 янв 2023 г. |
| Harsh Michael | A | 9634 | 9634 | 30 янв 2023 г. |
| Tokman Alexander Y | A | 9621 | 9621 | 30 янв 2023 г. |
| Basenese Lou | A | 6746 | 6746 | 30 янв 2023 г. |
| Thornton Michael Milos | A | 19139 | 1500 | 09 дек 2022 г. |
| Tokman Alexander Y | A | 162857 | 10000 | 23 ноя 2022 г. |
| Thornton Michael Milos | A | 352775 | 20000 | 22 авг 2022 г. |
Новостная лента
Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?
InvestorPlace
28 апр 2023 г. в 09:09
ENDRA Life Sciences (NASDAQ: NDRA ) stock is sliding lower on Friday after revealing details of its public offering. ENDRA Life Sciences is offering up 862,500 shares of NDRA stock alongside 431,250 warrants to purchase more shares.
ENDRA Life Sciences Inc. (NDRA) Q4 2022 Earnings Call Transcript
Seeking Alpha
14 мар 2023 г. в 19:31
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q4 2022 Earnings Conference Call March 14, 2023 4:30 PM ET Company Participants Yvonne Briggs – LHA Investor Relations Francois Michelon – Chairman and Chief Executive Officer Michael Thornton – Chief Technology Officer Irina Pestrikova – Senior Director-Finance Conference Call Participants Vernon Bernardino – H.C. Wainwright & Company Edward Woo – Ascendiant Capital Operator Good afternoon, and welcome to the ENDRA Life Sciences Incorporated Fourth Quarter 2022 Financial Results Conference Call.
ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
Business Wire
07 мар 2023 г. в 16:05
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and year ended December 31, 2022 on Tuesday, March 14, 2023 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m.
ENDRA Life Sciences Inc. (NDRA) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 18:31
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Yvonne Briggs - Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Renaud Maloberti - Chief Commercial Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode.
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
15 авг 2022 г. в 19:56
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike Thornton - Chief Technology Officer Renaud Maloberti - CCO Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Vernon Bernardino - H.C. Wainwright Operator Good day everyone, and welcome to the ENDRA Life Sciences' Second Quarter 2022 Financial Results Conference Call.